Annovis Bio Inc (ANVS)
8.29
+0.26
(+3.24%)
USD |
NYSE |
May 17, 16:00
8.30
+0.01
(+0.12%)
After-Hours: 20:00
Annovis Bio Accounts Payable (Quarterly): 4.107M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 4.107M |
December 31, 2023 | 1.293M |
September 30, 2023 | 1.926M |
June 30, 2023 | 1.173M |
March 31, 2023 | 4.153M |
December 31, 2022 | 3.961M |
September 30, 2022 | 1.846M |
June 30, 2022 | 0.9018M |
March 31, 2022 | 0.929M |
December 31, 2021 | 0.6881M |
September 30, 2021 | 0.2897M |
Date | Value |
---|---|
June 30, 2021 | 0.1148M |
March 31, 2021 | 0.8246M |
December 31, 2020 | 0.3419M |
September 30, 2020 | 0.1398M |
June 30, 2020 | 0.1244M |
March 31, 2020 | 0.0545M |
December 31, 2019 | 1.234M |
September 30, 2019 | 0.4251M |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.0104M |
December 31, 2018 | 0.0684M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
4.153M
Maximum
Mar 2023
1.226M
Average
0.8632M
Median
Accounts Payable (Quarterly) Benchmarks
ANI Pharmaceuticals Inc | 49.43M |
Ligand Pharmaceuticals Inc | 1.893M |
FibroGen Inc | 4.353M |
SINTX Technologies Inc | 0.636M |
Stereotaxis Inc | 3.307M |